Cargando…

Silver and Antibiotic, New Facts to an Old Story

The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barras, Frédéric, Aussel, Laurent, Ezraty, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163818/
https://www.ncbi.nlm.nih.gov/pubmed/30135366
http://dx.doi.org/10.3390/antibiotics7030079
_version_ 1783359452705980416
author Barras, Frédéric
Aussel, Laurent
Ezraty, Benjamin
author_facet Barras, Frédéric
Aussel, Laurent
Ezraty, Benjamin
author_sort Barras, Frédéric
collection PubMed
description The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics.
format Online
Article
Text
id pubmed-6163818
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61638182018-10-12 Silver and Antibiotic, New Facts to an Old Story Barras, Frédéric Aussel, Laurent Ezraty, Benjamin Antibiotics (Basel) Review The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics. MDPI 2018-08-22 /pmc/articles/PMC6163818/ /pubmed/30135366 http://dx.doi.org/10.3390/antibiotics7030079 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Barras, Frédéric
Aussel, Laurent
Ezraty, Benjamin
Silver and Antibiotic, New Facts to an Old Story
title Silver and Antibiotic, New Facts to an Old Story
title_full Silver and Antibiotic, New Facts to an Old Story
title_fullStr Silver and Antibiotic, New Facts to an Old Story
title_full_unstemmed Silver and Antibiotic, New Facts to an Old Story
title_short Silver and Antibiotic, New Facts to an Old Story
title_sort silver and antibiotic, new facts to an old story
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163818/
https://www.ncbi.nlm.nih.gov/pubmed/30135366
http://dx.doi.org/10.3390/antibiotics7030079
work_keys_str_mv AT barrasfrederic silverandantibioticnewfactstoanoldstory
AT aussellaurent silverandantibioticnewfactstoanoldstory
AT ezratybenjamin silverandantibioticnewfactstoanoldstory